Grove Bank & Trust Merck & Co., Inc. Transaction History

Grove Bank & Trust

$739 Million
Q1 2025

A detailed history of Grove Bank & Trust transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 17,097 shares of MRK stock, worth $1.38 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

17,097

Previous 15,288 11.83%

Holding current value

$1.38 Million

Previous $1.52 Million 0.92%

% of portfolio

0.21%

Previous 0.21%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$83.01 - $101.02 $150,165 - $182,745	1,809 Added 11.83%	17,097 $1.53 Million
Q4 2024 Jan 16, 2025	BUY	$96.31 - $114.76 $78,203 - $93,185	812 Added 5.61%	15,288 $1.52 Million
Q3 2024 Oct 11, 2024	BUY	$111.15 - $128.97 $19,784 - $22,956	178 Added 1.24%	14,476 $1.64 Million
Q2 2024 Jul 24, 2024	BUY	$123.8 - $132.96 $43,701 - $46,934	353 Added 2.53%	14,298 $1.77 Million
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $5,322 - $6,201	-47 Reduced 0.34%	13,945 $1.84 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $82,748 - $90,050	-826 Reduced 5.57%	13,992 $1.53 Million
Q3 2023 Oct 30, 2023	SELL	$102.95 - $114.33 $38,915 - $43,216	-378 Reduced 2.49%	14,818 $1.53 Million
Q2 2023 Jul 27, 2023	BUY	$108.61 - $118.38 $434 - $473	4 Added 0.03%	15,196 $1.75 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $351,334 - $392,017	-3,413 Reduced 18.34%	15,192 $1.62 Million
Q4 2022 Feb 03, 2023	SELL	$87.44 - $112.11 $1.02 Million - $1.31 Million	-11,715 Reduced 38.64%	18,605 $2.06 Million
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $6,677 - $7,501	79 Added 0.26%	30,320 $2.61 Million
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $116,385 - $131,928	-1,394 Reduced 4.41%	30,241 $2.76 Million
Q1 2022 Apr 22, 2022	SELL	$73.51 - $82.4 $8,894 - $9,970	-121 Reduced 0.38%	31,635 $2.6 Million
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $71,990 - $90,177	996 Added 3.24%	31,756 $2.43 Million
Q3 2021 Oct 28, 2021	BUY	$71.68 - $78.83 $90,675 - $99,719	1,265 Added 4.29%	30,760 $2.31 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $81,911 - $90,602	1,165 Added 4.11%	29,495 $2.29 Million
Q1 2021 Apr 23, 2021	BUY	$68.86 - $81.11 $17,352 - $20,439	252 Added 0.9%	28,330 $2.18 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $156,530 - $173,716	2,181 Added 8.42%	28,078 $2.3 Million
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $44,127 - $50,018	-603 Reduced 2.28%	25,897 $2.15 Million
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $156,191 - $177,728	2,218 Added 9.13%	26,500 $2.05 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $48,723 - $67,533	-769 Reduced 3.07%	24,282 $1.87 Million
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $87,820 - $99,095	-1,132 Reduced 4.32%	25,051 $2.28 Million
Q3 2019 Oct 30, 2019	BUY	$76.08 - $82.93 $132,683 - $144,629	1,744 Added 7.14%	26,183 $2.2 Million
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $126,969 - $148,330	-1,818 Reduced 6.92%	24,439 $2.05 Million
Q1 2019 Apr 26, 2019	SELL	$69.58 - $79.36 $41,539 - $47,377	-597 Reduced 2.22%	26,257 $2.18 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $178,235 - $206,839	-2,732 Reduced 9.23%	26,854 $2.05 Million
Q3 2018 Nov 07, 2018	SELL	$57.69 - $67.84 $155,878 - $183,303	-2,702 Reduced 8.37%	29,586 $2.1 Million
Q2 2018 Aug 03, 2018	SELL	$50.83 - $59.72 $87,325 - $102,598	-1,718 Reduced 5.05%	32,288 $1.96 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $5,350 - $6,219	105 Added 0.31%	34,006 $1.85 Million
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $26,119 - $31,189	506 Added 1.52%	33,901 $1.91 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $1.96 Million - $2.11 Million	33,395	33,395 $2.14 Million

Others Institutions Holding MRK

# of Institutions

3,889

Shares Held

1.88B

Call Options Held

16.9M

Put Options Held

14.9M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $204B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account